Bibliografia UJ CM

1/9
Max Topp, Monika Dlugosz-Danecka, Aleksander B[artłomiej] Skotnicki, Galina Salogub, Andreas Viardot, Andreas K. Klein, Georg Hess, Christian S. Michel, Sebastian Grosicki, Alex Gural, Sylvia E. Schwarz, Kerstin Pietzko, Ulrike Gartner, Andras Strassz, Leila Alland, Jiri Mayer.
Safety of AFM11 in the treatment of patients with B-cell malignancies : findings from two phase 1 studies
Trials
2023 : Vol. 24, nr 1, il., bibliogr., abstr.
Autor korespondencyjny: Ulrike Gartner
Open Access Creative Commons Attribution License CC-BY 4.0
e-ISSN: 1745-6215
AZ
ORG
AIF
IF: 2.500
Adres url:
2/9
Wojciech Jurczak, Sundra Ramanathan, Pratyush Giri, Alessandra Romano, Heidi Mocikova, Jill Clancy, Mariajose Lechuga, Michelle Casey, Joseph Boni, Agnieszka Giza, Georg Hess.
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma.
Leukemia & Lymphoma
2018 : Vol. 59, nr 3, s. 670-678, il., bibliogr. 21 poz., abstr.
Autor korespondencyjny: Wojciech Jurczak.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
Data udostępnienia w sposób otwarty: 2017-08-03
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.674
Adres url:
Streszczenie w PubMed:
3/9
Ajay K. Gopal, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Andrew Spencer, John Radford, Wojciech Jurczak, James Morton, Dolores Caballero, Sanjay Deshpande, Gary J. Gartenberg, Shean-sheng Wang, Rajendra N. Damle, Michael Schaffer, Sriram Balasubramanian, Jessica Vermeulen, Bruce D. Cheson, Gilles Salles.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
Journal of Clinical Oncology
2018 : Vol. 36, nr 23, s. 2405-2412
Autor korespondencyjny: Ajay K. Gopal.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
4/9
Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun-Fang Chiou, Joris Diels, Martin Dreyling.
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.
Leukemia & Lymphoma
2017 : Vol. 58, nr 12, s. 2824-2832
Autor korespondencyjny: Georg Hesss.
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.644
Adres url:
Streszczenie w PubMed:
DOI:
5/9
Wojciech Jurczak, Sundra Ramanathan, Pratyush Giri, Francesco Di Raimondo, Heidi Mocikova, Jill Clancy, Mariajose Lechuga, Michelle Casey, Joseph P. Boni, Agnieszka Giza, Georg Hess.
Comparison of 2 Doses of Intravenous (IV) Temsirolimus (Temsr) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (MCL).
Blood
2016 : Vol. 128, nr 22, s. 1775
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
6/9
Ajay K. Gopal, Stephen J. Schuster, Nathan Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Wojciech Jurczak, James Morton, Dzhelil Osmanov, Gary J. Gartenberg, Jessica Vermeulen, Sriram Balasubramanian, Shean-sheng Wang, Sanjay Deshpande, Gilles A. Salles.
Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study.
Blood
2016 : Vol. 128, nr 22, s. 1217
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
7/9
Martin Dreyling, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Marek Trneny, Fritz Offner, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Georg Hess, Isabelle Bence-Bruckler, Seok-Goo Cho, John Bothos, Jenna D. Goldberg, Christopher Enny, Shana Traina, Sriram Balasubramanian, Nibedita Bandyopadhyay, Steven Sun, Jessica Vermeulen, Aleksandra Rizo, Simon Rule.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Lancet
2016 : Vol. 387, nr 10020, s. 770-778, il., bibliogr. 29 poz., sum.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 47.831
Adres url:
Streszczenie w PubMed:
8/9
Owen A. O'Connor, Steven Horwitz, Tamas Masszi, Achiel Van Hoof, Peter Brown, Jeannette Doorduijn, Georg Hess, Wojciech Jurczak, Poul Knoblauch, Shanta Chawla, Gajanan Bhat, Mi Rim Choi, Jan Walewski, Kerry Savage, Francine Foss, Lee F. Allen, Andrei Shustov.
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.
Journal of Clinical Oncology
2015 : Vol. 32, nr 23, s. 2492-2499, il., bibliogr. 39 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 20.982
Adres url:
Streszczenie w PubMed:
9/9
Martin C. Muller, Umang Munjal, Philipp Erben, Thomas Lion, Gerlinde Mitterbauer-Hohendann, Hakim El Housni, Nancy Boeckx, Renata Zadro, Jiri Mayer, Peter Rohon, Jana Rulcova, Lykke Grubach, Kadri Raudsepp, Veli Kairisto, Francois-Xavier Mahon, Claude Preudhomme, Sandrine Hayette, Jean Gabert, Jean-Michel Cayuela, Christian Thiede, Lars Galonska, Heike Pfeifer, Carsten Hirt, Philippe Schafhausen, Nils von Neuhoff, Martin Roskos, Christiane Pott, Thoralf Lange, Georg Hess, Susanne Schnittger, Annika Dufour, Steffen Koschmieder, Frank Stegelmann, Katerina Zoi, Kostas Stamatopoulos, Hajnalka Andrikovics, Tali Tohami, Giovanni Martinelli, Barbara Izzo, Enrico Gottardi, Mindaugas Stoskus, Dag Andre Nymoen, Tomasz Sacha, Joana Diamond, Rodica Talmaci, Andrey Misyurin, Michael V. Dubina, Tadej Pajic, Josep F. Nomdedeu, Dolors Colomer, Gisela Barbany-Bustinza, Hans Ehrencrona, Elisabeth Oppliger Leibundgut, Jeroen Janssen, Vincent H.J. Van der elden, Peter J.M. Valk, Ugur Ozbek, Lihui Wang, Gareth Gerrard, Helen E. White, Thomas Schenk, Thomas Ernst, Rudiger Hehlmann, Giuseppe Saglio, Andreas Hochhaus, Nicholas C.P. Cross.
Stability of conversion factors for BCR-ABL monitoring - implications for the frequency of validation rounds.
Blood
2010 : Vol. 116, nr 21, abstr. 893
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ